Moreover, their study demonstrated no statistical correlation between PTX-3 levels and age, gender, peripheral blood leukocyte, or neutrophil counts, concluding that PTX-3 expression in bronchoalveolar fluid could be a diagnosis biomarker for lung cancer [132]. This evidence concerns the gene PTX3 and lung carcinoma.